Virtu Financial LLC Can Fite Bio Pharma Ltd. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.74 - $7.9 $20,387 - $217,652	-27,551 Reduced 48.92%	28,771 $22,000
Q2 2022 Aug 09, 2022	BUY	$0.83 - $1.24 $46,747 - $69,839	56,322 New	56,322 $52,000
Q2 2021 Sep 17, 2021	SELL	$1.97 - $2.48 $91,199 - $114,809	-46,294 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$1.8 - $2.92 $49,964 - $81,053	-27,758 Reduced 37.48%	46,294 $114,000
Q4 2020 Feb 24, 2021	BUY	$1.66 - $2.15 $100,401 - $130,038	60,483 Added 445.74%	74,052 $132,000
Q3 2020 Dec 11, 2020	SELL	$1.61 - $2.67 $29,359 - $48,690	-18,236 Reduced 57.34%	13,569 $24,000
Q2 2020 Aug 07, 2020	BUY	$1.28 - $2.5 $40,710 - $79,512	31,805 New	31,805 $63,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $36.7M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.